BioPoly has been granted a U.S. patent protecting the implantation method of its BioPoly® partial resurfacing devices. This closely follows a patent issued in January 2016, pertaining to partial resurfacing implant designs and method of implantation.
BioPoly has received CE mark approval on multiple applications of its resurfacing technology in joints such as the knee, patella and shoulder, and is expanding products and territories through its global distribution partner, OrthoD. BioPoly products are available in Europe and parts of Asia, though they have not yet been approved for use in the U.S.
BioPoly has been granted a U.S. patent protecting the implantation method of its BioPoly® partial resurfacing devices. This closely follows a patent issued in January 2016, pertaining to partial resurfacing implant designs and method of implantation.
BioPoly has received CE mark approval on multiple applications of its resurfacing...
BioPoly has been granted a U.S. patent protecting the implantation method of its BioPoly® partial resurfacing devices. This closely follows a patent issued in January 2016, pertaining to partial resurfacing implant designs and method of implantation.
BioPoly has received CE mark approval on multiple applications of its resurfacing technology in joints such as the knee, patella and shoulder, and is expanding products and territories through its global distribution partner, OrthoD. BioPoly products are available in Europe and parts of Asia, though they have not yet been approved for use in the U.S.
Copy to clipboard 
